Beta Bionics, Inc. (BBNX)

10.68 +0.11 (+1.04%) USD  |  NASDAQ  |  May 07, 11:41
More

Beta Bionics SG&A Expense (TTM) : 102.76M for March 31, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for BBNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Abbott Laboratories 13.01B
Insulet Corp. 904.30M
Tandem Diabetes Care, Inc. 444.99M
Accuray, Inc. 88.55M
Plus Therapeutics, Inc. 12.13M